Jan 02, 2008 -
For delivering mamas, the second stage of labor can be the most arduous, so some moms-to-be opt for a birth stool to help the process along. Said to widen the pelvis and allow gravity to naturally help the baby down while reducing the chance of tearing, the stool supports the woman while she does a standing squat. Normally made of wood like poplar or oak, the furniture piece has handles and soft edges for safety and costs between $100 to $250.
- 7 Comments
Oct 08, 2008 -
HEALTH GUIDE REFERENCE FROM A.D.A.M
Low Birth Weight
Low birth weight refers to infants who weigh less than 5.5 pounds at birth. Most normal babies weigh 5.5 pounds by 37 weeks of gestation. Intrauterine growth restriction refers to delayed growth within the uterus, which then leads to low birth weight.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the FDA approved LIALDA, the first once-daily mesalamine pill for treating mild-to-moderate ulcerative colitis. Other types of mesalamine need to be taken several times a day.
Genetic Research
Scientists have made an important discovery by identifying a gene associated with inflammatory bowel disease.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Symptoms
- Diagnosis
- Dietary Factors
- Treatment
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
FDA Issues Labeling Changes for Drugs That Boost Red Blood Cells
In November 2007, the U.S. Food and Drug Administration (FDA) made several changes to the prescribing labels for erythropoiesis-stimulating drugs. These drugs -- epoietin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) -- increase the production of red blood cells.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Treatment
- Treatment for NSAID-Induced...
- Medications
- Treatment for Bleeding Ulce...
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Risk with cardiovascular medications
While nonsteroidal anti-inflammatory drugs are the major medications responsible for causing peptic ulcers, drugs taken for cardiovascular disease and its risk factors may also cause ulcers. Recent studies have found an association between increased risk of ulcer and the following drugs:
- Spironolactone, a common diuretic used in heart failure
- Niacin, a drug used to lower "bad" cholesterol and raise "good" cholesterol
- Vitamin K antagonists, commonly prescribed anticoagulants
- Dipyridamole, a drug for secondary stroke prevention
- Low-dose aspirin, prescribed for both heart attack and stroke prevention
Risk of peptic ulcer increases dramatically when these drugs are used in combination. Considering the millions of people who take these medications to prevent a life-threatening cardiovascular event, their impact on peptic ulcer development could be monumental.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Biologic Drugs
- In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
- As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Treatment
- The American Academy of Sleep Medicine recommends medications for restless legs syndrome (RLS) or periodic limb movement disorder (PLMD) only for persons who fulfill strict diagnostic criteria and experience too much daytime sleepiness as a result of these conditions. (Excessive daytime sleepiness results from nighttime sleeplessness due to RLS or PLMD symptoms).
- The U.S. Food and Drug Administration (FDA) announced in March 2007 that the dopamine agonist drug pergolide (Permax) has been voluntarily withdrawn from the market.
- 2 Comments
Sep 03, 2008 -
Overview
- Definition
- Causes, incidence, and risk factors
- Symptoms
- Signs and tests
- Treatment
- Expectations (prognosis)
- Complications
- Calling your health care provider
Illustrations
Digestive system
Digestive system organs
Meckel's diverticulectomy - series
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
A Meckel's diverticulum is a common congenital (present from before birth) pouch on the wall of the small bowel. The diverticulum may contain stomach or pancreatic tissue.
Causes, incidence, and risk factors
A Meckel's diverticulum is a remnant of structures within the fetal digestive tract that were not fully reabsorbed before birth.
- 0 Comments
Sep 04, 2008 -
Overview
- Definition
- Considerations
- Common Causes
- Call your health care provider if
- What to expect at your health care provider's office
Illustrations
Lower digestive anatomy
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Stools that are pale, or clay- or putty-colored may result from problems in the biliary system (the drainage system of the gallbladder, liver, and pancreas).
Considerations
The liver releases bile salts into the stool, giving it a normal brown color. You may have clay-colored stools if you have a liver infection or if the flow of bile out of the liver is blocked.
- 0 Comments